Skip to content
Information Technology, Medical Health Aged Care

Study finds AI can predict cybersickness in VR users

Charles Darwin University 2 mins read

Artificial Intelligence (AI) could be used to help combat nausea, headaches and dizziness among virtual reality (VR) users and make the technology more accessible, according to a new study with Charles Darwin University (CDU). 

The study by CDU and Torrens University researchers explored using AI techniques and machine learning algorithms to predict cybersickness for potential users of VR technology with headsets. The study was conducted by Fawad Zaidi, Associate Professor Niusha Shafiabady and Emeritus Professor Justin Beilby.    

Questionnaire data was split into two groups: people who will experience cybersickness symptoms within minutes of using VR devices, and people who wouldn’t have issues with using VR devices.

The data was processed through Ai-Labz, created by study co-author and CDU Faculty of Science and Technology Associate Professor Niusha Shafiabady. Results revealed AI could predict discomfort among VR users with 93 per cent accuracy.

Associate Professor Shafiabady said with growing use and need of VR technology, being able to effectively predict and prevent cybersickness was crucial.

“Most of the people feel discomfort after having a VR experience and having the ability to predict the occurrence of cybersickness for an individual, helps the VR developers and manufacturers to come up with solutions and take preemptive actions to create a better experience for the VR users and address the issues causing it,” she said.

“In the era of technology and especially after the Covid-19 pandemic, the need for remote access and virtual education has grown significantly. Cybersickness is one of the factors that hinders the users from using VR devices because of the great discomfort due to the VR experience.”

Associate Professor Shafiabady said the next step could be to use eXplainable AI algorithms to explore why the AI algorithms made its predictions, giving developers and manufacturers reason why users will have discomfort.

“We are moving towards the times where we use VR devices for essential activities such as servicing manufacturers remotely and teaching, to less essential but more fun activities like looking into the outer space through VR lens,” she said.

“In the era of technology, the VR users should be able to get the benefits of technology without suffering.”

The study, ‘Identifying presence of cybersickness symptoms using AI-based predictive learning algorithms’ was published in journal Virtual Reality

Read the full study here.


Contact details:

Raphaella Saroukos she/her
Communications Officer
Marketing, Media & Communications
T: +61 8 8946 6721
E: media@cdu.edu.au
W: cdu.edu.au


Media

More from this category

  • Information Technology
  • 13/09/2024
  • 21:11
Deriv Group

Deriv Honoured with ‘Best Customer Service’ Award at Global Forex Awards

Deriv’s client-first philosophy earns the 'Best Customer Service' award at the Global Forex Awards, coinciding with its 25th year of empowering traders.2024 is the year of wins for Deriv, which earlier this year won the ‘Most Trusted Broker’, ‘Best Trading Experience’ (LATAM) 2024, and ‘Best Latam Region Broker’ awards.LIMASSOL, Cyprus, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Deriv, a globally recognised online trading company with a 25-year legacy of trust, innovation, and service, has been recognised for its exceptional customer support by winning the ‘Best Customer Service’ award at the prestigious Global Forex Awards.The ‘Best Customer Service’ award, coinciding with Deriv’s…

  • Information Technology
  • 13/09/2024
  • 17:10
Ai-Media Technologies LLC

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

BROOKLYN, N.Y., Sept. 13, 2024 (GLOBE NEWSWIRE) -- AI-Media - the global leader in audiovisual encoding technology and AI-driven transcription and translation solutions, and Speechmatics - the market leader in speech recognition technology, today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.This partnership brings together Speechmatics’ leading speech-to-text technology and AI-Media’s unique iCap-based encoding appliances and secure network that seamlessly embeds the technology within customers’ existing workflows and automation systems.By integrating these capabilities, AI-Media's LEXI 3.0 has been the first AI product to overtake the quality of human-in-the-loop alternatives in the…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.